Market Closed -
Nasdaq
04:00:00 2025-07-11 pm EDT
5-day change
1st Jan Change
4.160 USD
-9.17%
-10.73%
-39.88%
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q2 Revenue $9.2M
Published on 08/08/2024 at 16:34,
updated on 08/08/2024 at 17:09
Sensus Healthcare, Inc., Q1 2025 Earnings Call, May 15, 2025
May. 23
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.
May. 15
CI
Sensus Healthcare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
May. 15
CI
Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting
Mar. 06
CI
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.
Mar. 05
CI
Sensus Healthcare Resumes $3 Million Share Buyback Plan
Feb. 11
MT
Sensus Healthcare, Inc., Q4 2024 Earnings Call, Feb 05, 2025
Feb. 05
Sensus Healthcare, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2025
Feb. 05
CI
Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024
Feb. 05
CI
Sensus Healthcare, Inc.'s Equity Buyback announced on March 9, 2022, has expired.
Dec. 30
CI
Pompano Veterinary Oncology Partners with Sensus Healthcare to Provide First Superficial Radiotherapy Services in A Mobile Configuration
Dec. 04
CI
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q3 Revenue $8.8M
Nov. 18
MT
Sensus Healthcare, Inc., Q3 2024 Earnings Call, Nov 14, 2024
Nov. 14
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q3 Revenue $8.8M
Nov. 14
MT
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.
Nov. 14
CI
Sensus Healthcare, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
Nov. 14
CI
Providence St. Joseph Health acquired SRT System from Sensus Healthcare, Inc..
24-09-24
CI
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.
24-08-13
CI
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q2 Revenue $9.2M
24-08-08
MT
Sensus Healthcare, Inc., Q2 2024 Earnings Call, Aug 08, 2024
24-08-08
Sensus Healthcare, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024
24-08-08
CI
Sensus Healthcare, Inc. Announces Resignation of John Heinrich from the Board of Directors
24-05-31
CI
Top MIdday Gainers
24-05-10
MT
Tranche Update on Sensus Healthcare, Inc.'s Equity Buyback Plan announced on August 8, 2023.
24-05-10
CI
Wall Street Set to Extend Gains on Thursday's Higher-Than-Expect Jobless Claims Report, Lifting US Equity Futures Pre-Bell
24-05-10
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
SRTS: Dynamic Chart
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
More about the company
Average target price
11.00 USD
Spread / Average Target
+164.42%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
Select your edition
All financial news and data tailored to specific country editions